Dyne Therapeutics (DYN) earnings, Jul 29, 2026: EPS −11%, stock +2.5%
In brief
Dyne Therapeutics reported on Jul 29, 2026. Earnings per share changed −11% year over year, 44.2% below the estimate; revenue 0%. The stock opened with a −2.4% gap and closed the day +2.5% (Jul 30, 2026). The stock is now 36.4% below its 52-week high, −16.9% over 12 months. Next report: Nov 5, 2026.
EPS vs estimate−44.2%
EPS, YoY−11%
Revenue, YoY0%
Gap · day−2.4% · +2.5%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 29, 2026 | −2.4% | +2.5% |
Next-quarter estimates, ratings and the DYN chart are in the terminal.
Open the terminalFAQ
When is Dyne Therapeutics's next earnings report?
Nov 5, 2026. The date comes from daily data and is corrected if the company moves it.
How did Dyne Therapeutics stock react to the report?
Opening gap −2.4%, day's result +2.5%.
Did Dyne Therapeutics's earnings grow?
Earnings per share fell 11% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.